A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering.
Zhu J, Ananthaswamy N, Jain S, Batra H, Tang WC, Lewry DA, Richards ML, David SA, Kilgore PB, Sha J, Drelich A, Tseng CK, Chopra AK, Rao VB.
Zhu J, et al. Among authors: sha j.
Sci Adv. 2021 Sep 10;7(37):eabh1547. doi: 10.1126/sciadv.abh1547. Epub 2021 Sep 8.
Sci Adv. 2021.
PMID: 34516878
Free PMC article.